Cargando…

Cdk5 phosphorylation-induced SIRT2 nuclear translocation promotes the death of dopaminergic neurons in Parkinson’s disease

NAD-dependent protein deacetylase Sirtuin 2 (SIRT2), which regulates several cellular pathways by deacetylating multiple substrates, has been extensively studied in the context of Parkinson’s disease (PD). Although several studies based on the MPTP model of PD show that SIRT2 deletion can protect ag...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Jianguo, Zhang, Pei, Tan, Jie, Li, Mao, Xu, Xingfeng, Shao, Xiaoyun, Fang, Fang, Zou, Zhenyou, Zhou, Yali, Tian, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021196/
https://www.ncbi.nlm.nih.gov/pubmed/35443760
http://dx.doi.org/10.1038/s41531-022-00311-0
_version_ 1784689751652040704
author Yan, Jianguo
Zhang, Pei
Tan, Jie
Li, Mao
Xu, Xingfeng
Shao, Xiaoyun
Fang, Fang
Zou, Zhenyou
Zhou, Yali
Tian, Bo
author_facet Yan, Jianguo
Zhang, Pei
Tan, Jie
Li, Mao
Xu, Xingfeng
Shao, Xiaoyun
Fang, Fang
Zou, Zhenyou
Zhou, Yali
Tian, Bo
author_sort Yan, Jianguo
collection PubMed
description NAD-dependent protein deacetylase Sirtuin 2 (SIRT2), which regulates several cellular pathways by deacetylating multiple substrates, has been extensively studied in the context of Parkinson’s disease (PD). Although several studies based on the MPTP model of PD show that SIRT2 deletion can protect against dopaminergic neuron loss, the precise mechanisms of SIRT2-mediated neuronal death have largely remained unknown. Here, we show that SIRT2 knockout can effectively ameliorate anomalous behavioral phenotypes in transgenic mouse models of PD. Importantly, in both cellular and animal models of PD, it was observed that SIRT2 translocates from the cytoplasm to the nucleus. Further, the nuclear translocation of SIRT2 promotes neuronal death. Moreover, the cyclin-dependent kinase 5 (Cdk5)-mediated phosphorylation of SIRT2 at the Ser331 and Ser335 sites appears to be necessary for such nuclear translocation. Taken together, the results provide insights into the mechanisms involved in the regulation of neuronal death during PD progression via the Cdk5-dependent nuclear–cytoplasmic shuttling of SIRT2.
format Online
Article
Text
id pubmed-9021196
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-90211962022-04-28 Cdk5 phosphorylation-induced SIRT2 nuclear translocation promotes the death of dopaminergic neurons in Parkinson’s disease Yan, Jianguo Zhang, Pei Tan, Jie Li, Mao Xu, Xingfeng Shao, Xiaoyun Fang, Fang Zou, Zhenyou Zhou, Yali Tian, Bo NPJ Parkinsons Dis Article NAD-dependent protein deacetylase Sirtuin 2 (SIRT2), which regulates several cellular pathways by deacetylating multiple substrates, has been extensively studied in the context of Parkinson’s disease (PD). Although several studies based on the MPTP model of PD show that SIRT2 deletion can protect against dopaminergic neuron loss, the precise mechanisms of SIRT2-mediated neuronal death have largely remained unknown. Here, we show that SIRT2 knockout can effectively ameliorate anomalous behavioral phenotypes in transgenic mouse models of PD. Importantly, in both cellular and animal models of PD, it was observed that SIRT2 translocates from the cytoplasm to the nucleus. Further, the nuclear translocation of SIRT2 promotes neuronal death. Moreover, the cyclin-dependent kinase 5 (Cdk5)-mediated phosphorylation of SIRT2 at the Ser331 and Ser335 sites appears to be necessary for such nuclear translocation. Taken together, the results provide insights into the mechanisms involved in the regulation of neuronal death during PD progression via the Cdk5-dependent nuclear–cytoplasmic shuttling of SIRT2. Nature Publishing Group UK 2022-04-20 /pmc/articles/PMC9021196/ /pubmed/35443760 http://dx.doi.org/10.1038/s41531-022-00311-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Yan, Jianguo
Zhang, Pei
Tan, Jie
Li, Mao
Xu, Xingfeng
Shao, Xiaoyun
Fang, Fang
Zou, Zhenyou
Zhou, Yali
Tian, Bo
Cdk5 phosphorylation-induced SIRT2 nuclear translocation promotes the death of dopaminergic neurons in Parkinson’s disease
title Cdk5 phosphorylation-induced SIRT2 nuclear translocation promotes the death of dopaminergic neurons in Parkinson’s disease
title_full Cdk5 phosphorylation-induced SIRT2 nuclear translocation promotes the death of dopaminergic neurons in Parkinson’s disease
title_fullStr Cdk5 phosphorylation-induced SIRT2 nuclear translocation promotes the death of dopaminergic neurons in Parkinson’s disease
title_full_unstemmed Cdk5 phosphorylation-induced SIRT2 nuclear translocation promotes the death of dopaminergic neurons in Parkinson’s disease
title_short Cdk5 phosphorylation-induced SIRT2 nuclear translocation promotes the death of dopaminergic neurons in Parkinson’s disease
title_sort cdk5 phosphorylation-induced sirt2 nuclear translocation promotes the death of dopaminergic neurons in parkinson’s disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021196/
https://www.ncbi.nlm.nih.gov/pubmed/35443760
http://dx.doi.org/10.1038/s41531-022-00311-0
work_keys_str_mv AT yanjianguo cdk5phosphorylationinducedsirt2nucleartranslocationpromotesthedeathofdopaminergicneuronsinparkinsonsdisease
AT zhangpei cdk5phosphorylationinducedsirt2nucleartranslocationpromotesthedeathofdopaminergicneuronsinparkinsonsdisease
AT tanjie cdk5phosphorylationinducedsirt2nucleartranslocationpromotesthedeathofdopaminergicneuronsinparkinsonsdisease
AT limao cdk5phosphorylationinducedsirt2nucleartranslocationpromotesthedeathofdopaminergicneuronsinparkinsonsdisease
AT xuxingfeng cdk5phosphorylationinducedsirt2nucleartranslocationpromotesthedeathofdopaminergicneuronsinparkinsonsdisease
AT shaoxiaoyun cdk5phosphorylationinducedsirt2nucleartranslocationpromotesthedeathofdopaminergicneuronsinparkinsonsdisease
AT fangfang cdk5phosphorylationinducedsirt2nucleartranslocationpromotesthedeathofdopaminergicneuronsinparkinsonsdisease
AT zouzhenyou cdk5phosphorylationinducedsirt2nucleartranslocationpromotesthedeathofdopaminergicneuronsinparkinsonsdisease
AT zhouyali cdk5phosphorylationinducedsirt2nucleartranslocationpromotesthedeathofdopaminergicneuronsinparkinsonsdisease
AT tianbo cdk5phosphorylationinducedsirt2nucleartranslocationpromotesthedeathofdopaminergicneuronsinparkinsonsdisease